An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Molecular Imaging and Contrast Agent Database (MICAD) [Internet].
Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
Top results in this bookTable of Contents
StatPearls [Internet].
Treasure Island (FL): StatPearls Publishing; 2023 Jan-.
Risk of Nephrogenic Systemic Fibrosis after Exposure to Newer Gadolinium Agents [Internet].
Goldstein KM, Lunyera J, Mohottige D, et al.
Washington (DC): Department of Veterans Affairs (US); 2019 Oct.
Endotext [Internet].
Feingold KR, Anawalt B, Blackman MR, et al., editors.
South Dartmouth (MA): MDText.com, Inc.; 2000-.
Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet].
York (UK): Centre for Reviews and Dissemination (UK); 1995-.
PDQ Cancer Information Summaries [Internet].
Bethesda (MD): National Cancer Institute (US); 2002-.
Optimizing Health System Use of Medical Isotopes and Other Imaging Modalities [Internet].
Mujoomdar M, Russell E, Dionne F, et al.
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2012.
Mechanosensitivity in Cells and Tissues.
Kamkin A, Kiseleva I, editors.
Moscow: Academia; 2005.
Drugs and Lactation Database (LactMed®) [Internet].
Bethesda (MD): National Institute of Child Health and Human Development; 2006-.
GeneReviews® [Internet].
Adam MP, Mirzaa GM, Pagon RA, et al., editors.
Seattle (WA): University of Washington, Seattle; 1993-2023.
Dilated Cardiomyopathy: From Genetics to Clinical Management [Internet].
Sinagra G, Merlo M, Pinamonti B, editors.
Cham (CH): Springer; 2019.
Clinical Review Report: Siponimod (Mayzent): (Novartis Pharmaceuticals Canada Inc.): Indication: Secondary-progressive multiple sclerosis [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2020 Sep.
Comparative Clinical and Cost-Effectiveness of Drug Therapies for Relapsing-Remitting Multiple Sclerosis [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2013 Oct. (CADTH Therapeutic Review, No. 1.2B.)
Preclinical MRI of the Kidney: Methods and Protocols [Internet].
Pohlmann A, Niendorf T, editors.
New York: Humana Press; 2021.
Holland-Frei Cancer Medicine. 6th edition.
Kufe DW, Pollock RE, Weichselbaum RR, et al., editors.
Hamilton (ON): BC Decker; 2003.
Clinical Review Report: Ocrelizumab (Ocrevus): (Hoffmann-La Roche Limited): Indication: Treatment of adult patients with relapsing-remitting multiple sclerosis (RRMS) with active disease defined by clinical and imaging features [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2017 Dec.
Clinical Review Report: Daclizumab (Zinbryta) [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2017 Jul.
Clinical Review Report: Ofatumumab (Kesimpta): (Novartis Pharmaceuticals Canada Inc.): Indication: Multiple sclerosis, relapsing-remitting [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2021 Apr.
Clinical Review Report: Cladribine (Mavenclad): (EMD Serono): Indication: As monotherapy for the treatment of adult patients with relapsing-remitting multiple sclerosis (RRMS) to reduce the frequency of clinical exacerbations and delay the progression of disability. Cladribine is generally recommended in RRMS patients who have had an inadequate response to, or are unable to tolerate, one or more therapies for RRMS [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2018 Oct.
Systematic review and modelling of the cost-effectiveness of cardiac magnetic resonance imaging compared with current existing testing pathways in ischaemic cardiomyopathy.
Campbell F, Thokala P, Uttley LC, et al.
Southampton (UK): NIHR Journals Library; 2014 Sep. (Health Technology Assessment, No. 18.59.)
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on